2024 annual financial data
Lexicon Pharmaceuticals 2024 Operating margin
Direct answer
Operating margin was -634.2%.
Operating income was -197,117,000 USD and net income was -200,403,000 USD.
Operating cash flow was -178,780,000 USD.
Get free Lexicon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 31,081,000 USD
- Operating income
- -197,117,000 USD
- Net income
- -200,403,000 USD
- Operating cash flow
- -178,780,000 USD